MFIM
BFRI icon

Mesirow Financial Investment Management’s Biofrontera BFRI Stock Holding History

Mesirow Financial Investment Management’s Portfolio BFRI Stock Details BFRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-890
Closed -$10.9K – 83
2023
Q1 		$10.9K Buy
+890
New +$13.9K 0.05% 73

Other funds holding BFRI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Mesirow Financial Investment Management's BFRI Position: Q2 2023 in Review

Mesirow Financial Investment Management sold out of Biofrontera (BFRI) in Q2 2023, closing a stake of 890 shares — an estimated $10.9K sold.

Mesirow Financial Investment Management first reported a position in BFRI in Q1 2023 and held it in 1 quarter. The position peaked at $10.9K in Q1 2023. 13 funds tracked by Wall St. Rank hold BFRI as of Q2 2023.

  • Mesirow Financial Investment Management reported no remaining Biofrontera position as of Q2 2023 after selling out during the quarter.
  • Mesirow Financial Investment Management sold 890 Biofrontera shares in Q2 2023, an estimated $10.9K.
  • Mesirow Financial Investment Management first reported a position in Biofrontera in Q1 2023 and held it in 1 quarter.
  • Mesirow Financial Investment Management's Biofrontera position peaked at $10.9K in Q1 2023.
  • 13 funds tracked by Wall St. Rank held Biofrontera as of Q2 2023.

Based on Mesirow Financial Investment Management's 13F filing for Q2 2023, filed 17 Jul 2023.